AbbVie Inc.
ABBV
$210.75
-$0.79-0.37%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.44% | -0.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.44% | -0.01% | |||
| Cost of Revenue | 5.35% | 0.12% | |||
| Gross Profit | 4.07% | -0.07% | |||
| SG&A Expenses | -20.74% | 20.64% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.96% | 8.59% | |||
| Operating Income | 20.15% | -16.31% | |||
| Income Before Tax | -208.88% | -2.89% | |||
| Income Tax Expenses | -531.92% | -32.73% | |||
| Earnings from Continuing Operations | -101.47% | 13.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 133.33% | 0.00% | |||
| Net Income | -101.41% | 13.94% | |||
| EBIT | 20.15% | -16.31% | |||
| EBITDA | 13.83% | -12.16% | |||
| EPS Basic | -102.06% | 13.99% | |||
| Normalized Basic EPS | 18.47% | -17.78% | |||
| EPS Diluted | -102.13% | 13.99% | |||
| Normalized Diluted EPS | 18.66% | -17.78% | |||
| Average Basic Shares Outstanding | 0.00% | 0.06% | |||
| Average Diluted Shares Outstanding | -0.17% | 0.06% | |||
| Dividend Per Share | 5.81% | 0.00% | |||
| Payout Ratio | -71.98% | -0.12% | |||
